OR7-6: Safety and efficacy of ARX201: six month dose-ranging study of a novel long-acting pegylated growth hormone in young adults with growth hormone deficiency

✍ Scribed by Racz, K.; Coculescu, M.; Olyinik, V.; Popa, M.; Popovic, V.; Radiuk, K.; Senatorova, A.S.; Vlasenko, M.V.; Norman, T.; Juhasz, M.; Hoffman, A.R.; Axelrod, D.W.

• Book ID: 126758805
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 444 KB
• Volume: 24
• Category: Article
• ISSN: 1096-6374
• DOI: 10.1016/S1096-6374(14)50052-4